<DOC>
	<DOC>NCT02273492</DOC>
	<brief_summary>Comparative pharmacokinetics and pharmacodynamics of Asasantin ER at fasted and fed state</brief_summary>
	<brief_title>Impact of Food on Pharmacokinetics and Pharmacodynamics of Asasantin ER in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Aspirin, Dipyridamole Drug Combination</mesh_term>
	<criteria>Healthy subjects as determined by results of screening Signed written informed consent in accordance with good clinical practice (GCP) and local legislation Age ≥ 18 and ≤ 55 years Broca ≥ 20 % and ≤ + 20 % Any findings of the medical examination (including blood pressure, pulse rate and ECG) deviating from normal and of clinical relevance Gastrointestinal, hepatic, renal, respiratory, cardiovascular, metabolic, immunological or hormonal disorders Surgery of the gastrointestinal tract (except appendectomy) Diseases of the central nervous system (such as epilepsy) or psychiatric disorders Chronic or relevant acute infections History of hypersensitivity to Asasantin ER and any of the excipients Intake of drugs with a long halflife (&gt; 24 hours) (&lt; 1 month prior to administration or during the trial) Use of any drugs which might influence the results of the trial (≤ 10 days prior to administration or during the trial) Participation in another trial with an investigational drug (&lt; 1 month prior to administration or during the trial) Known alcohol abuse Known drug abuse Blood donation (&lt; 1 month prior to administration) Excessive physical activities (&lt; 5 days prior to administration) History of hemorrhagic diatheses History of gastrointestinal ulcer, perforating or bleeding History of bronchial asthma Any laboratory value outside the normal range of clinical relevance Female subjects: Pregnancy Positive pregnancy test No adequate contraception (adequate contraception e.g. sterilization, intrauterine devices (IUD), oral contraceptives) Inability to maintain this adequate contraception during the whole study period Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>